financetom
Business
financetom
/
Business
/
Goldman Sachs, BofA shareholders reject proposals for CEO-chair split
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Goldman Sachs, BofA shareholders reject proposals for CEO-chair split
Apr 24, 2024 10:02 AM

SALT LAKE CITY, Utah, NEW YORK April 24 (Reuters) -

Goldman Sachs ( GS ) and Bank of America ( BAC )

shareholders voted against proposals to divide the CEO and

chairman roles at both banks on Wednesday, bucking pressure from

influential proxy advisers to bolster corporate governance.

Proxy advisers Institutional Shareholder Services (ISS)

and Glass Lewis had urged shareholders to support the moves and

strip Goldman CEO David Solomon and BofA CEO Brian Moynihan of

their chairman roles.

Norway's $1.6 trillion sovereign wealth fund, one of the

world's largest investors, had also indicated support for the

plan.

At Goldman's annual shareholder meeting, the proposal by

the conservative-leaning National Legal and Policy Center (NPLC)

garnered 33% of shareholder votes, according to a preliminary

tally, compared with 16% last year.

Solomon's "poor decision making" led to substantial losses

in its retail division, Luke Perlot, associate director of the

NLPC's corporate integrity project, told investors as he

presented the proposal.

After the vote failed, Perlot said the CEO's misjudgments

"may have been avoided had there been a serious counterweight to

his power."

He added: "we are pleased that voting in support doubled

from last year, we are disappointed that these clear examples of

excesses did not convince a majority to support our proposal."

A Goldman Sachs ( GS ) spokesperson referred to the company's

earlier comments on the matter. Its governance committee has

maintained that it considers a strong lead independent director,

alongside the chairman-CEO role, as most effective at this time.

"We took decisive action to narrow our strategic focus

and play to our core strengths," Solomon told the meeting in his

opening remarks. "We are delivering on this strategy and putting

the firm in a stronger position."

A similar move at Bank of America ( BAC ) to separate the CEO and

chairman roles also failed after receiving 31% of shareholder

votes, compared with 26% last year.

At both banks, investors approved all management proposals,

including those on executive compensation, while rejecting all

shareholder proposals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Copyright 2023-2026 - www.financetom.com All Rights Reserved